Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rex Fang & Innovation Equity Premium Income ETF vs Heron Therapeutics Inc — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $41.87, while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Rex Fang & Innovation Equity Premium Income ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| FEPI | HRTX | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $49.54 | $1.49 |
52-Week Low | $37.98 | $0.32 |
Market Cap | — | $61.47M |
Enterprise Value | — | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
